Clinical Trial

Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation

Name: Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation — clinical trial record (NCT04322890)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PIKACHU

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess the Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation.

Protocol Amendment History 6 amendments

This ClinicalTrials.gov record has been amended 6 times since 2020-03-24; most recent amendment 2024-10-19.

Trial Details

NCT Number	NCT04322890
Lead Sponsor	Hunan Province Tumor Hospital
Conditions	Non Small Cell Lung Cancer, EGFR Gene Mutation, ALK Gene Mutation, ROS1 Gene Mutation, MET Gene Mutation
Enrollment	6,000 participants
Start Date	2020-04-16
Primary Completion	2026-12-24 (estimated)
Study Completion	2027-12-24 (estimated)
Updated on ClinicalTrials.gov	2024-10-22